The past decades have witnessed hyperthermia therapy (HTT) as an emerging strategy
against malignant tumors. Nanomaterial‐based photothermal therapy (PTT) and magnetic …

Vaccines containing novel adjuvant formulations are increasingly reaching advanced
development and licensing stages, providing new tools to fill previously unmet clinical …

Efficient delivery of small interfering (si) RNA to specific cell populations in vivo remains a
formidable challenge to its successful therapeutic application. We show that siRNA …

Chemotherapy turns tumor cells into “tumor vaccines” by immunogenic cell death (ICD).
However, it remains a challenge to exploit chemotherapy‐induced “tumor vaccines” for solid …

Toll-like receptors (TLRs) are a family of pattern-recognition receptors that are an important
link between innate and adaptive immunity. Many established, as well as experimental …

Coccidiosis is a ubiquitous intestinal protozoan infection of poultry seriously impairing the
growth and feed utilization of infected animals. Conventional disease control strategies rely …

Most childhood infections occur via the mucosal surfaces, however, parenterally delivered
vaccines are unable to induce protective immunity at these surfaces. In contrast, delivery of …

Adjuvant, as an important part of vaccines, can observably enhance the magnitude, breadth
and durability of immune responses. Nanoadjuvants, as novel vaccine adjuvants, have …

Most pathogens initiate their infections at the human mucosal surface. Therefore, mucosal
vaccination, especially through oral or intranasal administration routes, is highly desired for …

Complexing TLR9 agonists such as plasmid DNA to cationic liposomes markedly
potentiates their ability to activate innate immunity. We therefore reasoned that liposomes …